Rasyid A, Pemila U, Aisah S, Harris S, Wiyarta E, Fisher M. Exploring the self-efficacy and self-care-based stroke care model for risk factor modification in mild-to-moderate stroke patients.
Front Neurol 2023;
14:1177083. [PMID:
37251214 PMCID:
PMC10213644 DOI:
10.3389/fneur.2023.1177083]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Accepted: 04/12/2023] [Indexed: 05/31/2023] Open
Abstract
Context
The worldwide burden of stroke is projected to grow unless proper stroke education is implemented. Information alone cannot promote patient self-efficacy and self-care and reduce risk factors.
Aim
This trial aimed to test self-efficacy and self-care-based stroke education (SSE) on changes in self-efficacy, self-care, and risk factor modification.
Design setting and participants
This study is a single-center, double-blinded, interventional, two-arm randomized controlled trial with a 1- and 3-month follow-up in Indonesia. Between January 2022 and October 2022, 120 patients were prospectively enrolled from Cipto Mangunkusumo National Hospital, Indonesia. Participants were assigned using a computer-generated random number list.
Intervention
SSE was given before discharge from the hospital.
Primary outcome measure
Self-care, self-efficacy, and stroke risk score was measured 1 month and 3 months after discharge.
Secondary outcome measure
Modified Rankin Scale, Barthel Index, and blood viscosity was measured at 1 month and 3 months after discharge.
Results
A total of 120 patients (intervention n = 60; standard care n = 60) were randomized. In the 1st month, the intervention group showed a more significant change in self-care (4.56 [95% CI: 0.57, 8.56]), self-efficacy (4.95 [95% CI: 0.84, 9.06]), and stroke risk (-2.33 [95% CI:-3.19, -1.47]) compared to the controlled group. In the 3rd month, the intervention group also showed a more significant change in self-care (19.28 [95% CI: 16.01, 22.56]), self-efficacy (19.95 [95% CI: 16.61, 23.28]), and stroke risk (-3.83 [95% CI: -4.65, -3.01]) compared to the controlled group.
Conclusion
SSE may boost self-care and self-efficacy, adjust risk factors, enhance functional outcomes, and decrease blood viscosity.
Clinical trial registration
ISRCTN11495822.
Collapse